Literature DB >> 10695727

Pathogenic autoantibodies to neuronal proteins in neurological disorders.

A Vincent1, O Lily, J Palace.   

Abstract

Autoantibodies to acetylcholine receptors and to voltage-gated calcium and potassium channels are thought to be pathogenic in three peripheral neurological disorders: myasthenia gravis, the Lambert Eaton syndrome and acquired neuromyotonia. However, evidence for the role of antibodies in conditions involving the central nervous system, is scanty or unclear. This review describes the ways in which the roles of autoantibodies have been defined in the peripheral diseases, and discusses the more controversial evidence for involvement of autoantibodies in some central disorders such as multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10695727     DOI: 10.1016/s0165-5728(99)00210-6

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

1.  Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21 in thymic hyperplasia.

Authors:  Rozen Le Panse; Géraldine Cizeron-Clairac; Jacky Bismuth; Sonia Berrih-Aknin
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

2.  Striatal hypermetabolism in limbic encephalitis.

Authors:  Caroline Rey; Lejla Koric; Eric Guedj; Olivier Felician; Elsa Kaphan; José Boucraut; Mathieu Ceccaldi
Journal:  J Neurol       Date:  2011-11-12       Impact factor: 4.849

3.  Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease.

Authors:  Boris Sakic; David L Kirkham; David A Ballok; James Mwanjewe; Ian M Fearon; Joseph Macri; Guanhua Yu; Michelle M Sidor; Judah A Denburg; Henry Szechtman; Jonathan Lau; Alexander K Ball; Laurie C Doering
Journal:  J Neuroimmunol       Date:  2005-09-29       Impact factor: 3.478

4.  Oral human immunoglobulin for children with autism and gastrointestinal dysfunction: a prospective, open-label study.

Authors:  Cindy K Schneider; Raun D Melmed; Leon E Barstow; F Javier Enriquez; James Ranger-Moore; James A Ostrem
Journal:  J Autism Dev Disord       Date:  2006-11

5.  Autoantibodies against opioid or glutamate receptors are associated with changes in morphine reward and physical dependence in mice.

Authors:  Francesca Capone; Walter Adriani; Maria Shumilina; Galina Izykenova; Oleg Granstrem; Svetlana Dambinova; Giovanni Laviola
Journal:  Psychopharmacology (Berl)       Date:  2008-02-12       Impact factor: 4.530

Review 6.  LGI Proteins and Epilepsy in Human and Animals.

Authors:  A Pakozdy; M Patzl; L Zimmermann; T S Jokinen; U Glantschnigg; A Kelemen; D Hasegawa
Journal:  J Vet Intern Med       Date:  2015-06-01       Impact factor: 3.333

Review 7.  Remyelination-promoting human IgMs: developing a therapeutic reagent for demyelinating disease.

Authors:  A E Warrington; M Rodriguez
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

8.  Immunization with DAT fragments is associated with long-term striatal impairment, hyperactivity and reduced cognitive flexibility in mice.

Authors:  Walter Adriani; Susanne Koot; Sandra Columba-Cabezas; Emilia Romano; Domenica Travaglini; Ruud van den Bos; Oleg Granstrem; Syed F Ali; Giovanni Laviola
Journal:  Behav Brain Funct       Date:  2012-11-28       Impact factor: 3.759

Review 9.  Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms.

Authors:  Sarosh R Irani; Jeffrey M Gelfand; Adam Al-Diwani; Angela Vincent
Journal:  Ann Neurol       Date:  2014-07-10       Impact factor: 10.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.